Today: September 26, 2024
Today: September 26, 2024

New data reveal US space economy's output is shrinking – an economist explains in 3 charts

The space industry has changed dramatically since the Apollo program put men on the moon in the late 1960s.

Read More

Related

Science|Uncategorized

Polish zoo seeks name for newborn deer of tiny endangered species

Warsaw Zoo is seeking suggestions to name a female baby southern pudu, the second smallest deer species in the world, after its birth two months ago.

Polish zoo seeks name for newborn deer of tiny endangered species
Environment|Health|Science|Technology

Big lithium plans for Imperial Valley, one of California’s poorest regions, raise a bigger question: Who should benefit?

The promised ‘white gold rush’ would extract lithium alongside geothermal power production. The mineral is used in EV batteries, but even this less-polluting mining raises local health concerns.

Big lithium plans for Imperial Valley, one of California’s poorest regions, raise a bigger question: Who should benefit?
Health|Science

Fungal infections known as valley fever could spike this fall - 3 epidemiologists explain how to protect yourself

Cases of valley fever are typically most prevalent in California’s Central Valley and southern Arizona, but they have been increasing in California’s central and southern coastal areas.

Fungal infections known as valley fever could spike this fall - 3 epidemiologists explain how to protect yourself
Environment|Health|Science

Airdropping vaccines to eliminate canine rabies in Texas – two scientists explain the decades of research behind its success

Two rabies epidemics in animals spurred a state health emergency in Texas and a program that oversees annual mass wildlife vaccination. Millions of doses have been distributed since the ‘90s.

Airdropping vaccines to eliminate canine rabies in Texas – two scientists explain the decades of research behind its success
Health|Science

AbbVie's Parkinson's disease drug meets main goal in late-stage trial

AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday.

AbbVie's Parkinson's disease drug meets main goal in late-stage trial
Share This

Popular

Health|News|Science

How to make sure your generator doesn't kill you

How to make sure your generator doesn't kill you
Education|Health|Lifestyle|News|Science

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says
Business|Health|Science

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Health|News|Science

US health authorities need to play a larger role in cannabis policy, a new report says

US health authorities need to play a larger role in cannabis policy, a new report says